Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 20
Gene Symbol: ABCA2
ABCA2
0.010 Biomarker disease BEFREE Our objective was to compare two methods of measuring meningioma volume: (1) the simplified ellipsoid (ABC/2) method; and (2) perimetric volume measurements using imaging software modules. 31401721 2019
Entrez Id: 7043
Gene Symbol: TGFB3
TGFB3
0.010 AlteredExpression disease BEFREE We analyzed the expression of TGF-β3 at the mRNA level in 38 frozen meningioma samples. 30703597 2019
Entrez Id: 117
Gene Symbol: ADCYAP1R1
ADCYAP1R1
0.010 Biomarker disease BEFREE Additionally, procaspase-3 expressing glioma and meningioma cell lines were sensitive to the apoptotic effects of PAC-1 at biologically relevant exposures achievable in cancer patients. 30859090 2019
Entrez Id: 2348
Gene Symbol: FOLR1
FOLR1
0.010 Biomarker disease BEFREE Tissue samples of 27 human meningioma specimens and 7 canine meningioma specimens were immunohistochemically stained for FRα along with normal dura, skeletal muscle, and kidney tissue. 30113687 2019
Entrez Id: 79651
Gene Symbol: RHBDF2
RHBDF2
0.010 Biomarker disease BEFREE This study demonstrates the use of FAM-TOC in the selective fluorescent identification of meningioma cells in vitro. 30877475 2019
Entrez Id: 3791
Gene Symbol: KDR
KDR
0.010 AlteredExpression disease BEFREE The clinicopathological analysis of receptor tyrosine kinases in meningiomas: the expression of VEGFR-2 in meningioma was associated with a higher WHO grade and shorter progression-free survival. 30519894 2019
Entrez Id: 3183
Gene Symbol: HNRNPC
HNRNPC
0.010 AlteredExpression disease BEFREE In addition, we have for the first time identified significantly higher hnRNP family expression in meningioma and pituitary adenoma compared to normal brain tissue. 31698554 2019
Entrez Id: 1630
Gene Symbol: DCC
DCC
0.010 Biomarker disease BEFREE The DCC netrin 1 receptor (DCC) is a candidate gene for early meningioma progression. 31083655 2019
Entrez Id: 9987
Gene Symbol: HNRNPDL
HNRNPDL
0.010 AlteredExpression disease BEFREE In addition, we have for the first time identified significantly higher hnRNP family expression in meningioma and pituitary adenoma compared to normal brain tissue. 31698554 2019
Entrez Id: 768
Gene Symbol: CA9
CA9
0.010 Biomarker disease BEFREE We compared the expression patterns of the hypoxia marker carbonic anhydrase IX (CA-IX) in meningiomas with predominant clear cell (n = 15), microcystic (n = 9), or angiomatous (n = 11) morphologies, as well as 117 cases of other World Health Organization recognized histological meningioma variants. 31589317 2019
Entrez Id: 6271
Gene Symbol: S100A1
S100A1
0.010 Biomarker disease BEFREE The expression rate of SSTR2a was higher than that of conventional markers of meningioma, including EMA (86/138), PR (32/68) and S100 (1/125). 31208995 2019
Entrez Id: 55181
Gene Symbol: SMG8
SMG8
0.010 Biomarker disease BEFREE Our objective was to compare two methods of measuring meningioma volume: (1) the simplified ellipsoid (ABC/2) method; and (2) perimetric volume measurements using imaging software modules. 31401721 2019
Entrez Id: 9295
Gene Symbol: SRSF11
SRSF11
0.010 Biomarker disease BEFREE The multivariate analysis in JR-NET2 showed that embolization for tumors other than meningioma was the only significant risk factor for complication (odds ratio [OR], 3.88; 95% confidence interval [CI], 1.13-12.10; p = 0.032), and that in JR-NET3 revealed that embolization for feeders other than external carotid artery (ECA) (OR, 3.56; 95% CI, 2.03-6.25; p < 0.001) and use of liquid materials (OR, 2.65; 95% CI, 1.50-4.68; p < 0.001) were significant risks for complications. 31172282 2019
Entrez Id: 10100
Gene Symbol: TSPAN2
TSPAN2
0.010 GeneticVariation disease BEFREE The multivariate analysis in JR-NET2 showed that embolization for tumors other than meningioma was the only significant risk factor for complication (odds ratio [OR], 3.88; 95% confidence interval [CI], 1.13-12.10; p = 0.032), and that in JR-NET3 revealed that embolization for feeders other than external carotid artery (ECA) (OR, 3.56; 95% CI, 2.03-6.25; p < 0.001) and use of liquid materials (OR, 2.65; 95% CI, 1.50-4.68; p < 0.001) were significant risks for complications. 31172282 2019
Entrez Id: 6418
Gene Symbol: SET
SET
0.010 Biomarker disease BEFREE Novel proteins identified and validated in meningioma included the nuclear proto-oncogene SET, the splicing factor SF2/ASF and the higher-grade specific protein, HK2, involved in cellular metabolism. 30594554 2019
Entrez Id: 30818
Gene Symbol: KCNIP3
KCNIP3
0.010 Biomarker disease BEFREE Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. 31591222 2019
Entrez Id: 6285
Gene Symbol: S100B
S100B
0.010 Biomarker disease BEFREE The expression rate of SSTR2a was higher than that of conventional markers of meningioma, including EMA (86/138), PR (32/68) and S100 (1/125). 31208995 2019
Entrez Id: 59341
Gene Symbol: TRPV4
TRPV4
0.010 Biomarker disease BEFREE The above data support that TRPV1-4 channels are implicated in meningioma pathogenesis, and TRPV4 has predictive significance in the disease. 31119368 2019
Entrez Id: 8624
Gene Symbol: PSMG1
PSMG1
0.010 Biomarker disease BEFREE Additionally, procaspase-3 expressing glioma and meningioma cell lines were sensitive to the apoptotic effects of PAC-1 at biologically relevant exposures achievable in cancer patients. 30859090 2019
Entrez Id: 3251
Gene Symbol: HPRT1
HPRT1
0.010 AlteredExpression disease BEFREE TUBB, HPRT and ACTB were the most stably expressed genes for all analysis groups across meningioma and non-pathological meningeal tissue combined. 29079997 2018
Entrez Id: 23521
Gene Symbol: RPL13A
RPL13A
0.010 AlteredExpression disease BEFREE After mRNA transcription of meningioma (WHO grade I-III) and meningeal tissue from three different experimental sample types (fresh tissue, primary cell cultures and FFPE tissue), 13 candidate reference genes (ACTB, B2M, HPRT, VIM, GAPDH, YWHAZ, EIF4A2, MUC1, ATP5B, GNB2L, TUBB, CYC1, RPL13A) were chosen for quantitative expression analysis. 29079997 2018
Entrez Id: 25976
Gene Symbol: TIPARP
TIPARP
0.010 AlteredExpression disease BEFREE We report the up regulation of AHR pathway genes like aryl hydrocarbon receptor nuclear translocator (ARNT), aldehyde dehydrogenase1family memberA3 (ALDH1A3), cytochrome P450, family1, subfamily A polypeptide1 (CYP1A1) and TCCD induced poly ADP ribose polymerase (TIPARP) gene expression in human meningioma. 29302888 2018
Entrez Id: 7431
Gene Symbol: VIM
VIM
0.010 AlteredExpression disease BEFREE After mRNA transcription of meningioma (WHO grade I-III) and meningeal tissue from three different experimental sample types (fresh tissue, primary cell cultures and FFPE tissue), 13 candidate reference genes (ACTB, B2M, HPRT, VIM, GAPDH, YWHAZ, EIF4A2, MUC1, ATP5B, GNB2L, TUBB, CYC1, RPL13A) were chosen for quantitative expression analysis. 29079997 2018
Entrez Id: 113451
Gene Symbol: AZIN2
AZIN2
0.010 Biomarker disease BEFREE Meningioma with hard consistency shows significant correlation with several features including en plaque appearance (p = 0.0427), higher ADC value (p = 0.0046) and ratio (p = 0.0016), absent of prominent enhanced rim (p = 0.0306), absent of enostotic spur (p = 0.0040) and absent of vascular core (p = 0.0133) in univariate analysis but no significant correlation is found in multivariate analysis in all except ADC ratio. 29709881 2018
Entrez Id: 1543
Gene Symbol: CYP1A1
CYP1A1
0.010 AlteredExpression disease BEFREE We report the up regulation of AHR pathway genes like aryl hydrocarbon receptor nuclear translocator (ARNT), aldehyde dehydrogenase1family memberA3 (ALDH1A3), cytochrome P450, family1, subfamily A polypeptide1 (CYP1A1) and TCCD induced poly ADP ribose polymerase (TIPARP) gene expression in human meningioma. 29302888 2018